Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial, a Randomized, Double-Blind, Multicenter Clinical Trial
The purpose of this study is to determine the safety and effectiveness of the combination of low-dose aspirin and a medication called clopidogrel in reducing the risk of stroke, heart attacks and other complications in patients who have just had a TIA or minor ischemic stroke. (Enrolling in Jacksonville, FL)
Keywordstransient ischemic attack, TIA, ischemic stroke
Principal InvestigatorScott Silliman, AST PROFESSOR
Begin a new search for other research studies
Studies listed on this site have been approved by a UF Institutional Review Board (IRB), which works to ensure the welfare and rights of research participants as required by federal regulations. Study listings are provided by the UF Clinical and Translational Science Institute in collaboration with UF research teams and the UF IRBs.